These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 7775232)
21. Evaluation of metronomic cyclophosphamide chemotherapy as maintenance treatment for dogs with appendicular osteosarcoma following limb amputation and carboplatin chemotherapy. Matsuyama A; Schott CR; Wood GA; Richardson D; Woods JP; Mutsaers AJ J Am Vet Med Assoc; 2018 Jun; 252(11):1377-1383. PubMed ID: 29772973 [TBL] [Abstract][Full Text] [Related]
22. Canine Osteosarcoma Treated by Post-Amputation Sequential Accelerated Doxorubicin and Carboplatin Chemotherapy: 38 Cases. Frimberger AE; Chan CM; Moore AS J Am Anim Hosp Assoc; 2016; 52(3):149-56. PubMed ID: 27008320 [TBL] [Abstract][Full Text] [Related]
23. Toxicity and efficacy of cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma. Chun R; Garrett LD; Henry C; Wall M; Smith A; Azene NM J Am Anim Hosp Assoc; 2005; 41(6):382-7. PubMed ID: 16267062 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of single-agent chemotherapy for treatment of clinically evident osteosarcoma metastases in dogs: 45 cases (1987-1991). Ogilvie GK; Straw RC; Jameson VJ; Walters LM; Lafferty MH; Powers BE; Withrow SJ J Am Vet Med Assoc; 1993 Jan; 202(2):304-6. PubMed ID: 8428842 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of Weight Change During Carboplatin Therapy in Dogs With Appendicular Osteosarcoma. Story AL; Boston SE; Kilkenny JJ; Singh A; Woods JP; Culp WTN; Skorupski KA; Lu X J Vet Intern Med; 2017 Jul; 31(4):1159-1162. PubMed ID: 28503759 [TBL] [Abstract][Full Text] [Related]
26. STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial. Vail DM; Kurzman ID; Glawe PC; O'Brien MG; Chun R; Garrett LD; Obradovich JE; Fred RM; Khanna C; Colbern GT; Working PK Cancer Chemother Pharmacol; 2002 Aug; 50(2):131-6. PubMed ID: 12172978 [TBL] [Abstract][Full Text] [Related]
29. What's new in orthopedics. Harasen G Can Vet J; 2007 Feb; 48(2):199. PubMed ID: 17334037 [No Abstract] [Full Text] [Related]
30. Bone allografts and adjuvant cisplatin for the treatment of canine appendicular osteosarcoma in 18 dogs. Morello E; Buracco P; Martano M; Peirone B; Capurro C; Valazza A; Cotto D; Ferracini R; Sora M J Small Anim Pract; 2001 Feb; 42(2):61-6. PubMed ID: 11263699 [TBL] [Abstract][Full Text] [Related]
31. Prognostic importance of alkaline phosphatase activity in serum from dogs with appendicular osteosarcoma: 75 cases (1990-1996). Ehrhart N; Dernell WS; Hoffmann WE; Weigel RM; Powers BE; Withrow SJ J Am Vet Med Assoc; 1998 Oct; 213(7):1002-6. PubMed ID: 9776998 [TBL] [Abstract][Full Text] [Related]
32. Which dogs with appendicular osteosarcoma benefit most from chemotherapy after surgery? Results from an individual patient data meta-analysis. Schmidt AF; Groenwold RH; Amsellem P; Bacon N; Klungel OH; Hoes AW; de Boer A; Kow K; Maritato K; Kirpensteijn J; Nielen M Prev Vet Med; 2016 Mar; 125():116-25. PubMed ID: 26796424 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of P16 expression in canine appendicular osteosarcoma. Murphy BG; Mok MY; York D; Rebhun R; Woolard KD; Hillman C; Dickinson P; Skorupski K BMC Vet Res; 2017 Jun; 13(1):189. PubMed ID: 28633676 [TBL] [Abstract][Full Text] [Related]
34. Intensity of perioperative analgesia but not pre-treatment pain is predictive of survival in dogs undergoing amputation plus chemotherapy for extremity osteosarcoma. Nolan MW; Uzan OC; Green NA; Lana SE; Lascelles BDX Vet Comp Oncol; 2022 Sep; 20(3):568-576. PubMed ID: 35257492 [TBL] [Abstract][Full Text] [Related]
35. Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs. Phillips B; Powers BE; Dernell WS; Straw RC; Khanna C; Hogge GS; Vail DM J Am Anim Hosp Assoc; 2009; 45(1):33-8. PubMed ID: 19122062 [TBL] [Abstract][Full Text] [Related]
36. Toxicity and efficacy of a novel doxorubicin and carboplatin chemotherapy protocol for the treatment of canine appendicular osteosarcoma following limb amputation. Lane A; Black M; Wyatt K Aust Vet J; 2012 Mar; 90(3):69-74. PubMed ID: 22339117 [TBL] [Abstract][Full Text] [Related]
37. Adverse events and outcomes in dogs with appendicular osteosarcoma treated with limb amputation and a single subcutaneous infusion of carboplatin. Santamaria AC; Simcock JO; Kuntz CA J Am Vet Med Assoc; 2019 Aug; 255(3):345-351. PubMed ID: 31298641 [TBL] [Abstract][Full Text] [Related]
38. Predictors of outcome in dogs treated with adjuvant carboplatin for appendicular osteosarcoma: 65 cases (1996-2006). Saam DE; Liptak JM; Stalker MJ; Chun R J Am Vet Med Assoc; 2011 Jan; 238(2):195-206. PubMed ID: 21235373 [TBL] [Abstract][Full Text] [Related]
39. High-dose methotrexate and leucovorin rescue in dogs with osteogenic sarcoma. Cotter SM; Parker LM Am J Vet Res; 1978 Dec; 39(12):1943-5. PubMed ID: 312044 [TBL] [Abstract][Full Text] [Related]
40. Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin. Kurzman ID; MacEwen EG; Rosenthal RC; Fox LE; Keller ET; Helfand SC; Vail DM; Dubielzig RR; Madewell BR; Rodriguez CO Clin Cancer Res; 1995 Dec; 1(12):1595-601. PubMed ID: 9815961 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]